Pharmacogenomics PGY-2 Residencies

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

tungsten87

Full Member
10+ Year Member
Joined
May 25, 2009
Messages
819
Reaction score
39
There are currently two PGY-2 Pharmacogenomics programs (Shands and St. Jude), does anyone think these will become more commonplace in the near future? Considering the possibility of implementing practical/affordable pharmacogenetic testing in the future this could be an interesting way to go.
 
I most defiantly hope so. Individualized medicine is supposed to be the next big thing. But then again pharmacokinetics was supposed to be the nest big thing (and it has to some extent).

EDIT- Pharmacist with the proper training could have a huge role here.
 
I forget all the examples, but I read a book about pharmacogenomics before pharmacy school and apparently there are several examples out there where it could be used but its never been adopted by physicians (i'm guessing due to costs and redundancy - eg still have to pull labs to see the effect). The only one that pops to mind where they could use it but don't is warfarin. Abacavir is the only drug I can think of that they currently do pharmacogenomics with.
 
I forget all the examples, but I read a book about pharmacogenomics before pharmacy school and apparently there are several examples out there where it could be used but its never been adopted by physicians (i'm guessing due to costs and redundancy - eg still have to pull labs to see the effect). The only one that pops to mind where they could use it but don't is warfarin. Abacavir is the only drug I can think of that they currently do pharmacogenomics with.

There is actually quite a lot of drugs you can use genomics with (very effective too) . I don't see the point with Coumadin since the crapshoot method for initial dosing is more cost effective and not" too" bad safety wise. With the genetic tests becoming cheaper I see this as a growing field.
 
yeah, it doesn't make sense to do genomic testing for warfarin because you always titrate to the proper INR, regardless of the presence of other drugs that may alter coagulation.
 
But anyway, back to the topic. My understanding is that the residency in UF is more literature searches and drug information vs. say actual work in the lab. I am not completely sure though.
 
Last edited:
But anyway, back to the topic. My understanding is that the residency in UF is more literature searches and drug information vs. say actual work in the lab. I am not completely sure though.

This is certainly the case. It is more of a drug info rotation where the resident will utilize current literature to help implement practical, cost-effective pharmacogenetic testing.
 
Top